Skip to Main Content

Advertisement

Skip Nav Destination

Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML

Blood Adv (2022) 6 (11): 3294–3303.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement